Europe Injectable Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Europe Injectable Drug Delivery Devices Market Trends and it is Segmented by Device Type (Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices [Prefilled Syringes, Injectable Pens, Auto-Injectors, Needle-free Injectors, and Other Device Types]), Therapeutic Application (Cardiovascular Disease, Diabetes, Oncology, Autoimmune Disorders, Hepatitis, and Other Therapeutic Applications), and Geography (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe). The market size and forecasts are provided in terms of value (USD million) for all the above segments.

Europe Injectable Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Injectable Drug Delivery Devices Industry Overview

The Europe injectable drug delivery devices market is moderately competitive and most of the companies are international players. With the increasing prevalence of diseases, technological advancements, and patient compliance, few other key market players are expected to enter the market in the coming years. Some of the major players include Baxter, Becton, Dickinson and Company, Lilly, Gerresheimer AG, Novo Nordisk A/S, Pfizer Inc., Schott AG, Terumo Corporation, Teva Pharmaceutical Industries Ltd, Recipharm AB, Stevanato Group., and West Pharmaceutical Services, Inc.

Europe Injectable Drug Delivery Devices Market Leaders

  1. Becton, Dickinson and Company

  2. Baxter

  3. Gerresheimer AG

  4. Lilly

  5. Teva Pharmaceutical Industries Ltd

  6. *Disclaimer: Major Players sorted in no particular order
Europe Injectables Drug Delivery Market Industry Concentration

Injectable Drug Delivery Devices Market in Europe Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?